GENE ONLINE|News &
Opinion
Blog

New Research Marks a Paradigm Shift in Countering Alzheimer’s Disease

by Arvind C. Shekhar
Share To
Alzheimer's disease (AD) is the most common neurodegenerative disease, with more than 40 million cases reported worldwide. AD is characterized by the aggregation of both the β-Amyloid (Aβ) proteins into plaques and of the tau proteins into neurofibrillary tangles (NFTs) known collectively as aggregates which cause brain cells to die and the brain to shrink.

It had been believed that aggregation begins in a single location, spreading from one brain region to the next. A key limiting factor in disease progression is at what rate these processes occur and how important the local replication of seeds and their spread over longer length scales between brain regions, are for determining the time scale of human disease. 

Recent results, reported in the journal Science Advances, have opened up new avenues of understanding the progress of Alzheimer's and other neurodegenerative diseases and possibly new ways that future treatments might be developed.

The researchers developed a mathematical model to simulate the progression of the disease and applied it to five different imaging datasets. By combining the five different datasets, the researchers observed that the mechanism controlling the rate of progression in Alzheimer's disease is the replication of aggregates in individual regions of the brain and not the spread of aggregates from one region to another.

GO Prime with only $1.49 now

LATEST
Study Explores Impact of Mach Number Variations on Richtmyer–Meshkov Instability Using DSMC Method
2026-01-25
Study Highlights Improved Outcomes in Mandibular Reconstruction Using Patient-Specific Implants
2026-01-25
Study Explores Role of Peer Recovery Coaches in Substance Use Recovery Programs Across the United States
2026-01-25
Study Finds No Link Between Parental Age and Offspring’s Preference for Youthful Faces
2026-01-25
Advancements in Genomic Classification of Corynebacterium diphtheriae Strains Address Microbial Resistance Challenges
2026-01-25
Study Identifies ITGB2 Axis as a Therapeutic Target in Melanoma Progression
2026-01-25
Amplicon Sequencing with Oxford Nanopore Technologies Evaluated for Detecting Small Ruminant Lentiviruses in Sheep
2026-01-25
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top